Get started
Author

Ching‐Yuan Kuo

Observed names: C.-Y. Kuo, CHING-YUAN KUO, Ching-Yuan Kuo, Ching-yuan Kuo
OpenAlex ID: A5113673670
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
2018 · Steven Horwitz, Owen A O'Connor, et al. · The Lancet · 739
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
2010 · A.M. Evens, B.D. Jovanovic, et al. · Annals of Oncology · 353
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients
2009 · Sung-Nan Pei, Chien-Hung Chen, et al. · Annals of Hematology · 211
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy
2012 · Sung-Nan Pei, Ming-Chun Ma, et al. · Annals of Hematology · 90
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations
2019 · Guo-Wang Lin, Caigang Xu, et al. · The Lancet Oncology · 70
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
2025 · Michael Wang, Michael Wang, et al. · Journal of Clinical Oncology · 66
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
2006 · Moan-Shane Tsai, Ching-Yuan Kuo, et al. · PubMed · 58
TMPRSS6 rs855791 Polymorphism Influences the Susceptibility to Iron Deficiency Anemia in Women at Reproductive Age
2014 · Sung-Nan Pei, Ming-Chun Ma, et al. · International Journal of Medical Sciences · 38
PDF
Significance of platelet activation in vascular access survival of haemodialysis patients
2003 · Y.-C. Chuang, J.-B. Chen, et al. · Nephrology Dialysis Transplantation · 29
Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia
2019 · Ying‐Jung Huang, Ming‐Chung Kuo, et al. · British Journal of Haematology · 16
PDF
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study
2018 · Ching-Yuan Kuo, Po-Nan Wang, et al. · Therapeutic Advances in Hematology · 16
Mediastinal Mass and Malignant Pleural Effusion in an Aleukemic Case With Pre-B Acute Lymphoblastic Leukemia
2009 · Sung-nan Pei, Ching-yuan Kuo, et al. · Journal of Pediatric Hematology/Oncology · 11
Distinct clinical characteristics of paroxysmal nocturnal hemoglobinuria in patients in Southern Taiwan: A multicenter investigation
2017 · Hui‐Ching Wang, Ching‐Yuan Kuo, et al. · The Kaohsiung Journal of Medical Sciences · 8
PDF
A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan
2021 · Sung-Nan Pei, Ming-Chung Wang, et al. · Scientific Reports · 4
PDF
Combination of Sarcopenia and Anemia Predicts Worse Outcome in Elderly Patients With Diffuse Large B-Cell Lymphoma
2023 · PI-HAN LIAO, YI-HSUAN CHUANG, et al. · In Vivo · 3
PDF
Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis
2022 · Pi-Han Liao, Ching-Yuan Kuo, et al. · Journal of Hematology · 3
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan
2022 · Wen-Li Hwang, Tsung-Chih Chen, et al. · International Journal of Hematology · 3
Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma
2014 · Liang‐Tsai Hsiao, Hwei‐Fang Tien, et al. · Hematological Oncology · 3
Safety and Efficacy of Nilotinib (NIL) in Patients (Pts) with Chronic Phase (CP) or Accelerated Phase (AP) Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib Mesylate (IM): Results from the Multicenter, Observational NOVEL Study in Taiwan
2015 · Ching-Yuan Kuo, Po-Nan Wang, et al. · Blood · 2
Hepatosplenic fungal infection in adult patients with acute leukemia.
2008 · Ming-Chun Ma, Ming-Chung Wang, et al. · PubMed · 2
NOVEL-1st: Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan
2018 · Hwang Wen-Li, Shao-Min Han, et al. · Blood · 1
Efficacy and Safety of Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Patients Aged ≥75 Years with Acute Myeloid Leukemia (AML) in the Phase 3 AZA-AML-001 Study
2016 · John F. Seymour, Rena Buckstein, et al. · Blood · 1
No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study
2014 · Ming-Chung Kuo, Tsai-Yun Chen, et al. · Blood · 1
Pegylated Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory and/or Elder Acute Myeloid Leukemia: The Preliminary Result of Phase II Trial
2014 · Hui-Jen Tsai, Ming-Chung Wang, et al. · Blood · 1
Metastatic urothelial carcinoma of upper urinary tract
2007 · Shau‐Hsuan Li, Wan‐Ting Huang, et al. · American Journal of Hematology · 1
PDF
Works count: 32
Citation count: 1,730
H-index: 11
I10-index: 12
Year
Topic
Type